Cargando…
Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer
Hedgehog (Hh) pathway is involved in epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) maintenance resulting in tumor progression. GDC-0449, an inhibitor of Hh pathway component smoothened (Smo) has shown promise in the treatment of various cancers including pancreatic cancer. Howev...
Autores principales: | Kumar, Vinod, Chaudhary, Amit Kumar, Dong, Yuxiang, Zhong, Haizhen A., Mondal, Goutam, Lin, Feng, Kumar, Virender, Mahato, Ram I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431907/ https://www.ncbi.nlm.nih.gov/pubmed/28490735 http://dx.doi.org/10.1038/s41598-017-01942-7 |
Ejemplares similares
-
The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis
por: Kumar, Virender, et al.
Publicado: (2019) -
Impact of miRNA-mRNA Profiling and Their Correlation on Medulloblastoma Tumorigenesis
por: Kumar, Vinod, et al.
Publicado: (2018) -
Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease
por: Ma, Jingyi, et al.
Publicado: (2022) -
Gemcitabine elaidate and ONC201 combination therapy inhibits pancreatic cancer in a KRAS mutated syngeneic mouse model
por: Mahato, Ram, et al.
Publicado: (2023) -
Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy
por: Xin, Xiaofei, et al.
Publicado: (2020)